Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Stock Report

| More
Strides Arcolab arm receives US FDA nod for Chemotherapy Drug

Strides Arcolab's subsidiary Onco Therapies Limited has received final ANDA approval for Oxaliplatin Injection 50mg/10mL and 100mg/20mL.

The company had receive tentative approval from USFDA in November 2011 based on a Para III filing. This approval was later converted to a Para IV filing based on which USFDA has now granted final approval.

According to IMS data, the US market for generic Oxaliplatin is approximately $1.5 billion.

Oxaliplatin is part of the oncology portfolio licensed to Pfizer for the US market and the product is available for immediate launch.

Oxaliplatin is a chemotherapy drug used to treat advanced cancer of the colon and rectum. It is used in combination with other medications to slow or stop cancer cell growth.

The Strides Arcolab Ltd. stock was trading at Rs.754.45, up by Rs.30.05 or 4.15%. The stock hit an intraday high of Rs.760.05 and low of Rs.729.

The total traded quantity was 0.49 lakhs compared to 2 week average of 0.40 lakhs.

Source: Equity Bulls

Posted On: 2012-08-07 23:16:29

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Panasonic Appliances India Company Ltd approves delisting proposal
Canara Bank clarifies on media reports regarding Raising of Equity Capital
Igarashi Motors India Ltd to consider quarterly results for Q2
EXIM Bank withdraws Nominee Director from ABG Shipyard Ltd
Kolte-Patil Developers appoints Shraddha Jain as Chief Financial Officer
PI Industries Ltd Board to consider Interim Dividend for 2014-15
Dewan Housing Finance Corporation Ltd Board to consider Interim Dividend for 2014-15
Puravankara Projects launches Purva Evoq in Gunidy, Chennai
Sakthi Sugars Ltd delists equity shares from MSE
Virat Industries Ltd appoints Whole Time Director
Two Directors resign from Syncom Healthcare Ltd
Geojit BNP Paribas Financial Services Ltd reappoints CJ George as MD
Unichem Laboratories Q2 net profit lower at Rs. 22.31 crores
Kolte-Patil Developers Q2 PAT falls to Rs. 12.70 crores
Geojit BNP Paribas Financial Services Q2 PAT zooms to Rs. 19.99 crores
Force Motors Q2 profit slips to Rs. 25.69 crores
Shishir Bajaj steps down as Chairman & MD of Bajaj Hindusthan Ltd
UltraTech Cement Q2 net profit jumps to Rs. 414.24 crores
Oberoi Realty Q2 PAT soars to Rs. 70.54 crores
Persistent Systems Q2 consolidated net profit up at Rs. 71.31 crores
Umang Dairies Ltd to consider Q2 results on November 5, 2014
MT Educare Ltd to consider quarterly results
Panacea Biotec Ltd to announce Q2 results on October 31, 2014
Indiabulls Securities Ltd to consider Q2 results on October 27, 2014
JSL Industries Ltd to announce second quarter results on November 3, 2014
Hester Biosciences Ltd appoints alternate directors
Ved Prakash Agrawal appointed as CFO of Bajaj Hindusthan Ltd
UltraTech Cement Ltd extends term of MD
Cera Sanitaryware reports jump in Q2 net profit at Rs. 15.75 crores
8K Miles Software Services Q2 PAT soars to Rs. 4.14 crores
Indag Rubber Q2 PAT rises to Rs. 8.75 crores
Diamond Power Infrastructure Q2 PAT rises to Rs. 40.31 crores
Liberty Shoes Q2 net profit up at Rs. 2.53 crores
Damodar Industries Q2 profit slides to Rs. 2.28 crores
Jay Bharat Maruti Q2 net profit climbs to Rs. 12.24 crores
Maharashtra Scooters Q2 net jumps to Rs. 47.65 crores
Capri Global Capital Ltd Q2 PAT higher at Rs. 23.57 crores
Sterling Holiday Resorts India Q2 loss reduces to Rs. 3.72 crores
Hindustan Media Ventures Q2 net profit climbs to Rs. 31.46 crores
Samkrg Pistons Q2 PAT up at Rs. 4.20 crores
Kitex Garments Q1 PAT zooms to Rs. 19.32 crores
Tata Sponge Iron Q2 PAT higher at Rs. 22.53 crores
Menon Bearings Q2 profit more than doubles to Rs. 3.08 crores
Chowgule Steamships Q2 loss widens to Rs. 4.94 crores
Bajaj Corp Q2 net profit up at Rs. 37.43 crores
Kirloskar Industries posts Q2 net profit of Rs. 30.20 crores
Kirloskar Brothers Investments Q2 net profit at Rs. 47.16 crores
Somany Ceramics Q2 PAT climbs to Rs. 10.50 crores
Praj Industries Q2 PAT surges to Rs. 24.87 crores
Supreme Petrochem Q1 PAT down to Rs. 10.74 crores




  

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2014